Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension

Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography

1989 • 8,119 citations

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

1978 • 7,562 citations

Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings

1986 • 6,155 citations

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

1990 • 5,586 citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2002 • 5,471 citations

Blood pressure, stroke, and coronary heart disease

1990 • 4,424 citations

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

1991 • 2,374 citations

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.

1994 • 1,687 citations

Prognostic implications of left ventricular hypertrophy

2001 • 716 citations

Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension

1998 • 652 citations

Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events

2004 • 640 citations

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

1994 • 623 citations

Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril

2001 • 551 citations

The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease

1992 • 467 citations

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol

2004 • 458 citations

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1995 • 389 citations

Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects

2001 • 334 citations

The Relative Effects of Left Ventricular Hypertrophy, Coronary Artery Disease, and Ventricular Dysfunction on Survival Among Black Adults

1995 • 331 citations

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1995 • 330 citations

Discussion

1997 • 315 citations

Reliability of echocardiographic assessment of left ventricular structure and function

1999 • 299 citations

Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.

1993 • 298 citations

Characteristics of 9194 Patients With Left Ventricular Hypertrophy

1998 • 296 citations

Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol

2003 • 258 citations

Association of carotid atherosclerosis and left ventricular hypertrophy

1995 • 242 citations

Impact of Different Partition Values on Prevalences of Left Ventricular Hypertrophy and Concentric Geometry in a Large Hypertensive Population

2000 • 231 citations

Some effects of within-person variability in epidemiological studies

1973 • 210 citations

Relations of Left Ventricular Mass to Demographic and Hemodynamic Variables in American Indians

1997 • 208 citations

Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials

1996 • 174 citations

Echocardiographic Left Ventricular Geometry in Hypertensive Patients with Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

2001 • 131 citations

Management of Essential Hypertension in Patients With Different Degrees of Left Ventricular Hypertrophy

1992 • 131 citations

Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group.

1985 • 120 citations

Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial

1989 • 112 citations

Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: The Strong Heart Study

2001 • 112 citations

Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease

1994 • 96 citations

1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial)

2004 • 1 citations